Fish oil supplements enhance the benefits of strength training in older women, a small Brazilian clinical trial suggests.
Fish oil supplements enhance the benefits of strength training in older women, a small Brazilian clinical trial suggests.
Researchers at Parana Federal University randomly assigned 45 healthy women (64 years of age ± 1.4 years) to one of three exercise groups: strengthening exercises 3 times a week for 90 days; the same regimen plus 2 g of fish oil per day starting the first day of exercise; and the same regimen plus 2 g of fish oil per day starting 60 days before beginning exercise. Muscle strength and functional capacity were evaluated before and after the exercise regimen. All groups showed increased muscle strength after 3 months of exercise, but the women who also took fish oil showed greater improvement in muscle strength and functional capacity and demonstrated changes in neural excitability in their muscles.
Length of supplementation didn’t affect improvements in strength or functional capacity, the authors observe. Women who took fish oil for an additional 60 days before beginning strength training showed no greater gains than those who took supplements only during the 90-day training period.
The study was published online January 4 in the American Journal of Clinical Nutrition.
“These results should be viewed with caution because the participant numbers were relatively small,” the authors write. “Other studies involving a larger sample and other combinations of training and supplementation period are required.”
Nevertheless, they note, fish oil “may be an attractive supplement for the elderly to maximize their neuromuscular responses to strength training, which is important to life quality.”
Fasting glucose at GDM diagnosis may predict postpartum glucose abnormalities
February 6th 2025A recent study suggests that elevated fasting glucose levels at the time of gestational diabetes diagnosis could be an early indicator of postpartum glucose intolerance, emphasizing the need for close monitoring after delivery.
Read More
Ulipristal plus misoprostol shows promise for medication abortion
February 5th 2025A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.
Read More
Identification and management of patients at increased risk for breast cancer
February 5th 2025With breast cancer being the most diagnosed invasive cancer in the United States, OB-GYN practitioners play a crucial role in identifying high-risk patients and guiding them through screening, prevention, and risk-reduction strategies.
Read More